We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Infectech announced it filed with the FDA to begin the production, marketing
and commercializing of its biophasic system devices intended for medical purposes
to cultivate and identify certain pathogenic microorganisms.
A new computer-aided detection (CAD) system can help radiologists detect polyps
in colons that contain contrast-enhanced fluid, says a new study that appears
in the January issue of the American Journal of Roentgenology.
Conor Medsystems announced that the underwriters of the company's recent initial
public offering of its common stock have exercised in full their over-allotment
option to purchase an additional 900,000 shares of the company's common stock
at a price of $13 per share, before deducting underwriting discounts and commissions.
BioCardia and Symphony Medical announced a mutually exclusive agreement for
development and commercialization of a combination product that combines Symphony
Medical's biotherapeutic technology and BioCardia device delivery technology
for the treatment of cardiac conduction disorders.
Chindex International announced an exclusive, multiyear
distribution agreement for the People's Republic of China with Intuitive Surgical,
the innovator and market leader in surgical robotics.
RetinaPharma announced it received 510(k) FDA clearance to market its TonoPach
device that enables more accurate intra-ocular pressure (IOP) determinations
in patients.
Devax announced that enrollment has been completed in the AXXESS PLUS clinical
study for the company's AXXESS Drug Eluting Bifurcation Stent System -- a multi-component
stent delivery system comprising self-expanding Nitinol stents specifically
engineered for the treatment of coronary and vascular bifurcation lesions.